Skip to content

ENDRA Life Sciences Inc.

NDRA

CIK 0001681682

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$5.17M
+38.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$14.59
+84.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$7.22M
Q1 May 2026
Cash
$4.82M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
1.27M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings